World · 27 Oct
Supreme Court: ‘ప్రభుత్వం కళ్లముందే ఇదంతా..’: ఔషధ ధరలపై సుప్రీం కీలక వ్యాఖ్యలు
AI summaryThe Supreme Court of India questioned the central government regarding the massive price difference between the Maximum Retail Price (MRP) and the actual selling price of medicines. The bench expressed concern that the system seems to favor pharmaceutical manufacturers and criticized the National Pharmaceutical Pricing Authority (NPPA) as seemingly useless, while the government defended its policy not to control the entire pharma sector.
1 outlet · 1 loaded term flagged